2014 Q1 Form 10-Q Financial Statement

#000035581114000015 Filed on May 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $335.7M $269.5M
YoY Change 24.58% -7.3%
Cost Of Revenue $204.4M $176.0M
YoY Change 16.14% -7.29%
Gross Profit $131.3M $93.46M
YoY Change 40.48% -7.3%
Gross Profit Margin 39.11% 34.68%
Selling, General & Admin $13.63M $10.93M
YoY Change 24.76% -9.78%
% of Gross Profit 10.38% 11.69%
Research & Development $20.49M $18.68M
YoY Change 9.66% -19.52%
% of Gross Profit 15.61% 19.99%
Depreciation & Amortization $19.83M $13.81M
YoY Change 43.6% 8.93%
% of Gross Profit 15.1% 14.77%
Operating Expenses $34.12M $29.61M
YoY Change 15.24% -16.18%
Operating Profit $97.18M $63.85M
YoY Change 52.19% -2.51%
Interest Expense -$600.0K $500.0K
YoY Change -220.0% -16.67%
% of Operating Profit -0.62% 0.78%
Other Income/Expense, Net $4.515M $1.900M
YoY Change 137.57% -42.18%
Pretax Income $101.7M $65.75M
YoY Change 54.66% -4.41%
Income Tax $33.13M $20.32M
% Of Pretax Income 32.57% 30.91%
Net Earnings $68.57M $45.43M
YoY Change 50.92% -1.97%
Net Earnings / Revenue 20.42% 16.86%
Basic Earnings Per Share $0.24 $0.16
Diluted Earnings Per Share $0.24 $0.16
COMMON SHARES
Basic Shares Outstanding 289.8M shares 142.5M shares
Diluted Shares Outstanding 293.4M shares 143.1M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.7M $518.5M
YoY Change -27.73% 22.63%
Cash & Equivalents $374.7M $442.6M
Short-Term Investments $76.00M
Other Short-Term Assets $29.20M $24.80M
YoY Change 17.74% 5.98%
Inventory $128.3M $130.1M
Prepaid Expenses
Receivables $171.3M $121.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $703.6M $795.3M
YoY Change -11.53% 1.14%
LONG-TERM ASSETS
Property, Plant & Equipment $358.9M $348.1M
YoY Change 3.12% 12.38%
Goodwill $307.4M
YoY Change
Intangibles $361.4M $28.61M
YoY Change 1163.11%
Long-Term Investments $109.0M $158.2M
YoY Change -31.1% 8.21%
Other Assets $802.5M $186.8M
YoY Change 329.58%
Total Long-Term Assets $1.161B $534.9M
YoY Change 117.14% 14.09%
TOTAL ASSETS
Total Short-Term Assets $703.6M $795.3M
Total Long-Term Assets $1.161B $534.9M
Total Assets $1.865B $1.330B
YoY Change 40.22% 5.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.40M $33.00M
YoY Change 95.14% -54.79%
Accrued Expenses $102.7M $76.65M
YoY Change 34.01% 34.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $167.1M $109.7M
YoY Change 52.41% -15.71%
LONG-TERM LIABILITIES
Long-Term Debt $263.8M $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $263.8M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $167.1M $109.7M
Total Long-Term Liabilities $263.8M $0.00
Total Liabilities $480.1M $167.7M
YoY Change 186.3% -9.3%
SHAREHOLDERS EQUITY
Retained Earnings $866.2M $701.4M
YoY Change 23.5%
Common Stock $499.3M $438.1M
YoY Change 13.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.385B $1.162B
YoY Change
Total Liabilities & Shareholders Equity $1.865B $1.330B
YoY Change 40.22% 5.98%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $68.57M $45.43M
YoY Change 50.92% -1.97%
Depreciation, Depletion And Amortization $19.83M $13.81M
YoY Change 43.6% 8.93%
Cash From Operating Activities $97.72M $97.42M
YoY Change 0.31% 59.37%
INVESTING ACTIVITIES
Capital Expenditures -$16.70M -$13.40M
YoY Change 24.63% -66.33%
Acquisitions
YoY Change
Other Investing Activities -$600.0K -$19.50M
YoY Change -96.92% -425.0%
Cash From Investing Activities -$17.30M -$32.88M
YoY Change -47.39% -2.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$6.228M -$6.592M
YoY Change -5.53% 167.29%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$15.33M -$11.67M
YoY Change 31.37% -19.56%
NET CHANGE
Cash From Operating Activities $97.72M $97.42M
Cash From Investing Activities -$17.30M -$32.88M
Cash From Financing Activities -$15.33M -$11.67M
Net Change In Cash $65.10M $52.87M
YoY Change 23.12% 312.5%
FREE CASH FLOW
Cash From Operating Activities $97.72M $97.42M
Capital Expenditures -$16.70M -$13.40M
Free Cash Flow $114.4M $110.8M
YoY Change 3.25% 9.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
478865778 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
490518149 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
56510321 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
64399679 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143046590 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
171337311 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
102721345 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63470093 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19483799 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
21975363 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22945622 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4009346 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
594415 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5034165 shares
CY2013Q4 us-gaap Assets
Assets
1764088434 USD
CY2014Q1 us-gaap Assets
Assets
1865052923 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
703600975 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
601186242 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
77055612 USD
CY2014Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
82710461 USD
CY2014Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
347917 USD
CY2013 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
48603 USD
CY2014Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
8715289 USD
CY2013Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1886080 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
29998513 USD
CY2014Q1 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
26605035 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
48603 USD
CY2014Q1 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
347917 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309591724 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
374688291 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
389678664 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
442552961 USD
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
309591724 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
374688291 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
52874297 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
65096567 USD
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
8754600 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
8734681 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50805478 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66074507 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
204440537 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
176035466 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2180428 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1614318 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
50879337 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
49258818 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13805949 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19825402 USD
CY2014Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.14
CY2014Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
20400000 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.309
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
341225 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
702580 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
702580 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
341225 USD
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-218409 USD
CY2013Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1495536 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2822207 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-25808 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
54520 USD
CY2014Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
5049229 USD
CY2013Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 USD
CY2013Q4 us-gaap Goodwill
Goodwill
307365845 USD
CY2014Q1 us-gaap Goodwill
Goodwill
307365845 USD
CY2014Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2014Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014Q1 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2014Q1 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
0 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
131298807 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
93463503 USD
CY2014Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
101692090 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
65753912 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20323345 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33126019 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10198080 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7889358 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12347433 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28290721 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30735336 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
39907356 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8275303 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-29860576 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
285354 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
706899 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-534133 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-133880 USD
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
361350000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
366175000 USD
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25517944 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
23582378 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
128349467 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
120074164 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
75081810 USD
CY2014Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
80959971 USD
CY2014Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
21871552 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
21409976 USD
CY2013Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
495413 USD
CY2014Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
325158 USD
CY2013Q4 us-gaap Investments And Cash
InvestmentsAndCash
416597246 USD
CY2014Q1 us-gaap Investments And Cash
InvestmentsAndCash
483655870 USD
CY2013Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
107005522 USD
CY2014Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
108967579 USD
CY2013Q4 us-gaap Liabilities
Liabilities
436484751 USD
CY2014Q1 us-gaap Liabilities
Liabilities
480129842 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1865052923 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1764088434 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
167121024 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
119980414 USD
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
263750000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
265625000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
107005522 USD
CY2014Q1 us-gaap Long Term Investments
LongTermInvestments
108967579 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11666429 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15325712 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32881808 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17299667 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
97721946 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
97422534 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
68566071 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
45430567 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4514544 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1900273 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
34121261 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
29609864 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
63853639 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
97177546 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
805880967 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
802531483 USD
CY2014Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-91250 USD
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-601749 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-3784041 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
8593112 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2491564 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5374911 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1292477 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3218201 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3692791 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
9194861 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1404860 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4189386 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18599926 USD
CY2014Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20380923 USD
CY2014Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
24487944 USD
CY2013Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
33136682 USD
CY2013Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12674970 USD
CY2014Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16417890 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28473764 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29225906 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6227631 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6592272 USD
CY2013Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3000000 USD
CY2014Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-1875000 USD
CY2013Q1 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
0 USD
CY2013Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
10627243 USD
CY2014Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
23856516 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9500 USD
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
35005 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
358920465 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357021225 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18683576 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20489227 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
269498969 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
866166533 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
818027861 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
335739344 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4036
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4613
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13632034 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10926288 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4742080 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3850063 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0233
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0277
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
1384923081 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0174
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0077
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.54
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.98
CY2014Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Capitalized Cost
ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost
239959 USD
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y345D
CY2014Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
331969 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1327603683 USD
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
540810 shares
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1800101 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143075465 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146718507 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144918406 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142534655 shares
CY2014Q1 gntx Effectof One Percentage Point Increaseon Borrowing Rate
EffectofOnePercentagePointIncreaseonBorrowingRate
2700000 USD
CY2014Q1 gntx Patentsand Other Assets Net
PatentsandOtherAssetsNet
24848059 USD
CY2013Q4 gntx Patentsand Other Assets Net
PatentsandOtherAssetsNet
25334600 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000355811
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145909992 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
GENTEX CORPORATION
CY2014Q1 dei Trading Symbol
TradingSymbol
gntx

Files In Submission

Name View Source Status
0000355811-14-000015-index-headers.html Edgar Link pending
0000355811-14-000015-index.html Edgar Link pending
0000355811-14-000015.txt Edgar Link pending
0000355811-14-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gntx-20140331.xml Edgar Link completed
gntx-20140331.xsd Edgar Link pending
gntx-20140331_cal.xml Edgar Link unprocessable
gntx-20140331_def.xml Edgar Link unprocessable
gntx-20140331_lab.xml Edgar Link unprocessable
gntx-20140331_pre.xml Edgar Link unprocessable
gntx3312014-10q.htm Edgar Link pending
gntx3312014-exx311.htm Edgar Link pending
gntx3312014-exx312.htm Edgar Link pending
gntx3312014-exx32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending